$0.458
+0.046 (+9.98%)Zum Schluss
SGRX im Vergleich zur Peergroup
In the context of the broader market, SGRX competes directly with industry leaders such as STKH and LWAY. With a market capitalization of $1.67M, it holds a significant position in the sector. When comparing efficiency, SGRX's gross margin of N/A stands against STKH's N/A and LWAY's 19.27%. Such benchmarking helps identify whether Sangrix Inc is trading at a premium or discount relative to its financial performance.
Finanzielle Entwicklung von Sangrix Inc.
Sangrix Inc has reported a negative net income of -$2,770,979 for Q3 2026, with a current ratio of 44.93 indicating high liquidity but poor profitability. The company has a total debt of $14,433,480 against a negative equity position, which raises serious concerns about its financial health.
Financials
Ähnliche Artikel
- CPI Report and the Stock Market: How to Read October 2026 Inflation Data Before the Fed DecidesOctober 2026 CPI lands Nov 10 with no year-over-year number and Fed hike odds near 80%. Learn how to read CPI, which stocks react, and how to plan for it.
- Are You Buying NVIDIA’s Earnings or Its CEO’s Perfect Image?An Alphio analysis of NVIDIA’s share-price timeline, operating results, governance uncertainty and upcoming earnings.
- Stock Market After the 2026 Midterms: What a Democratic Congress Means for InvestorsDemocrats swept Congress in the 2026 midterms. See how stocks reacted, what history says about post-midterm returns, and which sectors face new risks.
Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.